Comparative lipidomic profiling of African trypanosomes reveals metabolic distinctions impacting pan-species drug development
PLOS Neglected Tropical Diseases · 2026
DOI: 10.1371/journal.pntd.0014771 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift PLOS Neglected Tropical Diseases, 2026. Verfasst von Emily A Dickie und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Infection and Immunity, University of Glasgow, Glasgow, United Kingdom. Hauptthemen laut MEDLINE: Trypanosoma brucei brucei, Lipidomics, Trypanosomiasis, African, Trypanosoma congolense. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Scottish Metabolomics Network, Wellcome.
Abstract (Originalsprache)
African trypanosomes are a group of pathogens that cause disease in humans (human African trypanosomiasis; HAT) and animals (African animal trypanosomosis; AAT) across sub-Saharan Africa, leading to profound impacts on human health as well as economic instability. Achieving sustainable disease control requires a One Health approach, yet the development of urgently required pan-species chemotherapeutics is severely hindered by a lack of unified biological understanding of the causative species. A major bottleneck in drug discovery is the distinct in vitro requirements of the clinically relevant species. Whilst Trypanosoma brucei is typically cultured in FBS-supplemented culture, T. congolense , the primary cause of AAT, requires the use of goat serum. The differing serum supplementation requirements of these two trypanosome species point to metabolic distinctions, which may be important considerations in developing experimental systems to enable the identification and design of novel, pan-species therapies. In this study, untargeted LC-MS lipidomics analyses were conducted to determine the relative lipidomic profiles of T. brucei and T. congolense bloodstream form parasites. The use of a novel medium formulation that permits effective in vitro culture of both species revealed that their lipidomic profiles are distinct. Notably, ether phospholipids, key molecules in T. brucei lipid biology, are relatively absent in T. congolense . Furthermore, the T. brucei lipidome is enriched with shorter chain saturated lipids, whilst T. congolense exhibits a preference for longer-chain polyunsaturated fatty acids (PUFAs). These observations indicate that there are significant differences in the ways these parasites synthesise and remodel their lipid complement, highlighting an evolutionary divergence between the species that likely carries implications for host-pathogen interactions as well as trypanosome membrane biology. Crucially, defining the species-specific lipid dependencies provides the foundation for pan-species culture systems, thereby removing a critical barrier to the discovery and design of novel therapeutics effective against all African trypanosome species.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Infection and Immunity, University of Glasgow, Glasgow, United Kingdom.
- Shared Research Facilities (SRF), MVLS, University of Glasgow, Glasgow, United Kingdom.
- Division of Biomedical Sciences, University of the Highlands and Islands, Centre for Health Sciences, Inverness, United Kingdom.
- The Roslin Institute, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Midlothian, United Kingdom.
- Schools of Chemistry and Biology, Biomedical Sciences Research Complex, University of St Andrews, St Andrews, United Kingdom.
ORCID-Profile: Emily A Dickie, Stefan K Weidt, Gavin Blackburn, Pieter C Steketee
Förderung
- Wellcome Trust
- Scottish Metabolomics Network
- Wellcome
- Scottish Universities Life Sciences Alliance
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Dickie, E. A., Weidt, S. K., Haggarty, J., Blackburn, G., Doherty, M. K., Ritchie, R., Paxton, E., Young, S., Whitfield, P. D., Smith, T. K., Morrison, L. J., Barrett, M. P., & Steketee, P. C. (2026). Comparative lipidomic profiling of African trypanosomes reveals metabolic distinctions impacting pan-species drug development. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0014771
Vancouver
Dickie EA, Weidt SK, Haggarty J, Blackburn G, Doherty MK, Ritchie R, et al. Comparative lipidomic profiling of African trypanosomes reveals metabolic distinctions impacting pan-species drug development. PLOS Neglected Tropical Diseases. 2026. doi:10.1371/journal.pntd.0014771
BibTeX
@article{Dickie2026,
author = {Dickie, Emily A and Weidt, Stefan K and Haggarty, Jennifer and Blackburn, Gavin and Doherty, Mary K and Ritchie, Ryan and Paxton, Edith and Young, Simon and Whitfield, Phillip D and Smith, Terry K and Morrison, Liam J and Barrett, Michael P and Steketee, Pieter C},
title = {Comparative lipidomic profiling of African trypanosomes reveals metabolic distinctions impacting pan-species drug development},
journal = {PLOS Neglected Tropical Diseases},
year = {2026},
doi = {10.1371/journal.pntd.0014771}
}
EUVIMED